Valproic Acid 500 MG

DRUG3 trials

Sponsors

Tecnoquimicas, Desitin Arzneimittel GmbH, Kafrelsheikh University

Conditions

HealthyMigraine DisordersMultiple Drug Use

Phase 1

Bioavailability of Orfiril Long 500 mg Prolonged-Release Minitablets and Ergenyl Chrono 500 mg Prolonged-Release Tablets

CompletedNCT06214130

Desitin Arzneimittel GmbHMultiple Drug Use

Start: 2023-09-22End: 2023-11-18Updated: 2024-01-23

Phase 4

Bioequivalence Study of Sodium Divalproate Tablets 500 mg

CompletedNCT03914534

TecnoquimicasHealthy

Start: 2017-04-17End: 2019-02-12Updated: 2019-04-16

Valproate Versus Propranolol in Migraine

RecruitingNCT06485726

Kafrelsheikh UniversityMigraine Disorders

Start: 2023-01-23End: 2024-07-05Target: 600Updated: 2024-07-03